Advertisement

Die Onkologie pp 1417-1452 | Cite as

Tumoren im Kopf- und Halsbereich

  • T. G. Wendt
  • H. Iro
  • F. Waldfahrer

Zusammenfassung

Das Robert-Koch-Institut Berlin (www.rki.de) gab für das Jahr 1998 für Tumoren der Mundhöhle und des Pharynx (unter Einschluss von Karzinomen der Lippe und der Speicheldrüsen, ICD Coo-C13) eine Inzidenzrate von 19,71 für Männer und 7,05 für Frauen an. Damit liegt die Inzidenz im Vergleich zu anderen EU-Ländern für Männer im oberen Drittel und für Frauen im Mittelfeld.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ackervall J,Wennerberg L,Mertens F (2000) Chromosomal abnormalities in squamous cell carcinoma of the head and neck.Adv Otorhinolaryngol 56: 261–267Google Scholar
  2. Adelstein DJ,Sharan VM,EarleASetal. (1990) Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65: 1685–1691Google Scholar
  3. Aebersold DM, Beer KT, Laissue J, Hug S, Lollar A, Greiner RH, Djonov V (2000) Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 48: 17–25PubMedGoogle Scholar
  4. Al-Sarraf M, LeBlanc M, Giri PG et al. (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase Ill randomized Intergroup study 0099. J Clin Oncol 16: 1310–1317PubMedGoogle Scholar
  5. Ang KK, Peters U, Weber RS et al. (1994) Postoperative radiotherapy for cutaneous melanoma of the head and neck region.IntJ Radiat Oncol Biol Phys 30: 795–798Google Scholar
  6. Arcangeli G, Nervi C, Righini R, Creton G, Mirri MA, Guerra A (1983) Combined radiation and drugs: The effect of intraarterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol 1: 101–107Google Scholar
  7. Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, DalySchveitzer N (1996) Conbined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized study. Int J Radiat Oncol Biol Phys 36: 999–1004PubMedGoogle Scholar
  8. Bailey BJ (1993) Head u. Neck Surgery - Otolaryngology. JB Lippincott, PhiladelphiaGoogle Scholar
  9. Bataini P, Brugère J, Bernier j,Jaulerry C, Picot C,Ghossein NA (1982) Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus. Int J Radiat Oncol Biol Phys 8: 1277–86Google Scholar
  10. Beck-Bornhold HP, Dubben HH, Liertz-Petersen C, Willers H (1997) Hyper-fractionation: where do we stand? Radiother Oncol 43: 1–21Google Scholar
  11. Becker A, Bloching M, Klautke G, Kuhnt T, Koehler A, Buechele T, Berghaus A, Fietkau R, Dunst J (2000) Twice-a-week paclitaxel and two courses cisplatin simultaneous with hyperfractionated accelerated radiotherapy for advanced squamous cell carcinoma of the head and neck: phase I study. Proc Am Soc Clin Oncol 19: Abstr. 1683Google Scholar
  12. Becker N,WahrendorfJ (1997) Krebsatlas der Bundesrepublik Deutschland 1981–1990 Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  13. Bernier J, Domenge C, Eschwege F et al. (2001) Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery:results of EORTC Phase Ill Trial 22931. Int J Radiat Oncol Biol Phys 51 [Suppl 1]:Abstr 1Google Scholar
  14. Bier H (1994) Krebsepidemiologie. HNO 42: 390–392PubMedGoogle Scholar
  15. Bier H (1997)Therapieentscheidungen bei fortgeschrittenen Malignomen des OropharynxGoogle Scholar
  16. Bier H, Schultze M, Ganzer U (1993) Anmerkungen zur Nachsorge von Tumorpatienten. HNO 41: 47–54PubMedGoogle Scholar
  17. Bissett RJ, Fitzpatrick PJ (1988) Malignant submandibular gland tumors. A review of 91 patients. Am 1 Clin Oncol 11: 46–51Google Scholar
  18. Bocca E, Pignataro O (1967) A conservation technique in radical neck dissection. Ann Otol 76: 975–987Google Scholar
  19. Bockmühl U (1998) Bedeutung der Analyse genetischer Alterationen bei Kopf-Hals-Karzinomen. HNO 46: 74–83PubMedGoogle Scholar
  20. Bockmühl U, Küchler I, Petersen I (2000) Verbesserte Prognoseeinschätzung bei Kopf-Hals-Karzinomen durch neue genetische Marker. HNO 48: 451–456PubMedGoogle Scholar
  21. Borthne A, Kjellevold K, Kaalhus O,Vermund H (1986) Salivary gland malignant neoplasms:Treatment and prognosis.lnt J Radiat Oncol Biol Phys 12: 747–54Google Scholar
  22. Bosch FX, Homann N, Conradt C, Dietz A, Erber R (1999) p53-Mutationen/p53-Proteinüberexpression. HNO 47: 833–848Google Scholar
  23. Boyle JO, Hakim 1, Koch W et al. (1993) The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53: 4477–4480.PubMedGoogle Scholar
  24. Bradford CR, Zhu S, Poore J et al. (1997) p53 mutations as a prognostic marker in advanced laryngeal carcinoma. Department of Verterans Affairs Laryngeal Cancer Cooperative Study Group.Arch Otolarnyngol Head Neck Surg 123: 605–9Google Scholar
  25. Brizel DM, Albers ME, Fisher SR et al. (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. NEJM 338: 1798–804PubMedGoogle Scholar
  26. Brizel DM, Wasserman TH, Henke M et al. (2000) Phase Ill randomized trial of amifostine as a radiotprotector in head and neck cancer.J Clin On-col 18: 3339–3345Google Scholar
  27. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328: 159–163PubMedGoogle Scholar
  28. Brugere J, Guenel P, Leclerc A, Rodriguez J (1986) Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth.Cancer 57: 391–395Google Scholar
  29. Bschorer R, LingenfelserT, Kaiserling E,Schwenzer N (1993) Malignant lymphoma of the mucosa-associated lymphoid tissue (MALT)-consecutive unusual manifestation in the rectum and gingiva.J Oral Pathol Med 22: 190–192Google Scholar
  30. Burmeister BH, Smithers BM, Poulsen M, McLeod GR, Bryant G,Tripcony L, Thorpe C (1995) Radiation therapy for nodal disease in malignant melanoma. World J Surg 19: 369–371Google Scholar
  31. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays. Int J Radiat Oncol Biol Phys 8: 1923–1933PubMedGoogle Scholar
  32. Catterall M,Errington RD (1987) The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy. Intl Radiat Oncol Biol Phys 13: 1313–1318Google Scholar
  33. Clamon G H, Baatz L, Hoffman HT, Hussey DGH, Glascock M, McCulloch TM, Graham SM (1996) Neurotoxicity in a phase I trial of continuous infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer. Head and Neck 18: 236–241PubMedGoogle Scholar
  34. Conley JJ,von Fraenkel T (1956) Historical aspect of head and neck surgery. Ann Otol 65: 643–655Google Scholar
  35. Constantinidis J, Federspil P, Iro H (2000) Die funktionell und ästhetisch orientierte Rekonstruktion von Lippendefekten. HNO 48: 517–526PubMedGoogle Scholar
  36. Cooper JS, Pajak TF, Forastiere AA et al. (2002) Pattern of failure for resected advanced head and neck cancer treated by concurrent chemotherapy and radiation therapy:an analysis of RTOG 9501/Intergroup Phase III Trial.Int J Radiat Oncol Biol Phys 54 [Suppl]: Abstr 3Google Scholar
  37. Cummings BJ, Keane TJ, Pintilie M et al. and the ENT Group (1996) A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinoma of the larynx and pharynx. Int J Radiat Oncol Biol Phys 36 Suppl 1: 235Google Scholar
  38. Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE (1993) Otolaryngology - head and neck surgery,2nd edition.Mosby,St.LouisGoogle Scholar
  39. De Crevoisier R, Bourhis J, Domenge C et al. (1998) Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16: 3556–3562PubMedGoogle Scholar
  40. deBurgh Norman JE, McGurk M (1995) Color atlas and text of the salivary glands. Mosby-Wolfe, London St. LouisGoogle Scholar
  41. Decker DA (1983) et al. Adjuvant chemotherapy with cis-diamminedichloroplatinum II and 1–2-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 51: 1353–1355Google Scholar
  42. Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie (1997) Verhandlungsbericht. Springer, Berlin Heidelberg New York Tokyo, S 87–111Google Scholar
  43. Deutsche Krebsgesellschaft (2000) Kurzgefasste Interdisziplinäre Leitlinien 2000. Zuckschwerdt, München, S 69–91Google Scholar
  44. deVita VT, Hellman S, Rosenberg SA (eds) (2001) Cancer–principles and practice of oncology, 6th edition. Lippincott-Raven, Philadelphia pp 789–916Google Scholar
  45. deVries N, Gluckman JL (1991) Multiple primary tumors in the head and neck.Thieme, StuttgartGoogle Scholar
  46. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M (1997) A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44: 123–136PubMedGoogle Scholar
  47. Dobrowsky W, Naudé J (2000) Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.Radiother Oncol 57: 119–124Google Scholar
  48. Dost P, Schrader M,Talanow D (1994) Nutzen der Abdomensonographie und der Skelettszintigraphie bei derTNM-Einteilung von Tumoren im Kopf-Hals-Bereich. HNO 42: 418–421Google Scholar
  49. Dost P,Talanow DD, Kaiser S, Hirche H, Jahnke K (1996) Zum Zeitintervall zwischen Symptom- und Behandlungsbeginn bei Kopf- und Halstumoren. HNO 44: 492–496Google Scholar
  50. Draf W, Berghaus A (1993) Tumoren und Pseudotumoren („tumorähnliche Läsionen“) der frontalen Schädelbasis, ausgehend von der Nase, den Nasennebenhöhlen und dem Nasenrachenraum (einschließlich der operativen Zugänge). Rhinochirurgisches Referat. Eur Arch Otorhinolaryngol [Suppl I]: 105–186Google Scholar
  51. Duncan W, Orr JA, Arnott SJ,Jack WJ (1987) Neutron therapy for malignant tumours of the salivary glands.A report of the Edinburgh experience. Radiother Oncol 8: 97–104Google Scholar
  52. Eckardt A, Wildfang I, Karstens JH (1999) Simultaneous radiochemotherapy with taxol/carboplatin in advanced operable head-neck tumors. Preliminary results.Strahlenther Onkol 175: 11–13Google Scholar
  53. EI Gueddari B (1998) Final results of the VUMCA I randomized trial comparing neoadjuvant chemotherapy (CT) (BEC) plus radiotherapy (RT) to RT alone in undifferntiated nasopharyngeal carcinoma (UCNT). Proc Am Soc Clin Oncol 17: 1482 [Abstract]Google Scholar
  54. EI-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials.! Clin On-col 14: 838–847Google Scholar
  55. English GM (1996) Otolaryngology volume 5: Oncology of the head and neck.J.B. Lippincott, PhiladelphiaGoogle Scholar
  56. Ensley JF, Gutkind JS, Jacobs JR, Lippman SM (eds) (2003) Head and neck cancer. Emerging perspectives. Academic Press, AmsterdamGoogle Scholar
  57. Eschwege F, Sancho-Gamier H, Chassagne D et al. (1997) Results of a randomized trial of etanidazole combined with radiotherapy in head and neck carcinoma. Int J Radiat Oncol Biol Phys 39: 275–281PubMedGoogle Scholar
  58. Fahlbusch R, Neubauer U,Wigand M,Weidenbecher M, Röckelein G,Thierauf P, Sauer R (1989): Neuro-rhinosurgical treatment of aesthesioneuroblastoma. Acta Neurochir 100: 93–100PubMedGoogle Scholar
  59. Ferlito A (2000) Diseases of the larynx. Arnold, LondonGoogle Scholar
  60. Fietkau R, Steiner W (1997) Moderne Aspekte der Strahlen- und Chemotherapie im Hals-Nasen-Ohrenbereich. Verhandlungsbericht 1997, Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Springer, Berlin Heidelberg New York Tokyo, S 87–130Google Scholar
  61. Fietkau R, Steiner W (1997) Moderne Aspekte der Strahlen- und Chemotherapie im Hals-Nasen-Ohrenbereich. Verhandlungsbericht 1997, Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Springer, Berlin Heidelberg New York Tokyo, S 87130Google Scholar
  62. Fletcher GH (1980) Textbook of radiotherapy, 3rd edition. Lea and Febiger, PhiladelphiaGoogle Scholar
  63. Forastiere AA, Metch B, Schuller DE et al. (1992) Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versusmethotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.) Clin Oncol 10: 1245–1251Google Scholar
  64. Fracchiolla NS,Pignataro L,Capaccio P,Trecca D,Boletini A,Ottaviani A,PoIli E, Maiolo AT, Neri A (1995) Multiple genetic lesions laryngeal squamous cell carcinoma.Cancer 75: 1291–1301Google Scholar
  65. Fu KK, Leibel SA, Levine ML, Frielander LM, Boles R, Phillips TL (1977) Carcinoma of the major and minor salivary glands:Analysis of treatment results and sites and causes of failures. Cancer 40: 2882–2890PubMedGoogle Scholar
  66. Fu KK, PajakTF,Trotti A et al.for the RTOG (2000) A radiation therapy oncology group (RTOG) phase Ill randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 90003. Int J Radiat Oncol Biol Phys 48: 7–16Google Scholar
  67. Fu KK, Phillips TL, Silverberg IJ et al. (1987) Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group Randomized Trial.J Clin Oncol 5: 1410–1418Google Scholar
  68. Gilligan D, Slevin NJ (1991) Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol 64: 1147–1150PubMedGoogle Scholar
  69. Giri PGS,AI-Sarraf M, Fu KK et al. (1996) Improved survival with chemotherapy and radiation therapy versus radiation therapy alone in advanced nasopharyngeal cancer. Preliminary results of an intergroup randomized trial. INT 0099, SWOG 8892, RTOG 8817, ECOG 2388. Int J Radiat Oncol Biol Phys 36 [Suppl]: 162Google Scholar
  70. Glanzmann C (1990) Long-term results of postoperative and primary radiotherapy of carcinoma of the salivary glands: importance of dosage and target volume. Strahlenther Onkol 166: 183–189PubMedGoogle Scholar
  71. Grabenbauer GG, Mühlfriedel C, Rödel F et al. (2000) Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Intl Radiat Oncol Biol Phys; 48: 1041–1050Google Scholar
  72. Griffin TW, Pajak TF, Laramore GE, Duncan W, Richter MP, Hendrickson FR, Maor MH (1988) Neutron vs. photon irradiation of inoperable salivary gland tumors: results of an RTOG-MRC Cooperative Randomized Study. Int J Radiat Oncol Biol Phys 15: 1085–1090PubMedGoogle Scholar
  73. Habermalz Hi, FischerJJ (1976) Radiation therapy of malignant melanoma: Experience with high individual treatment doses. Cancer 38: 22582262Google Scholar
  74. Harwood AR, Beale FA, Cummings Bj, Keane TJ, Payne DG, Rider WD Rawlinson E, Elhakim T (1983) Supraglottic laryngeal carcinoma:An analysis of dose-time volume factors in 410 patients. Int J Radiat Oncol Biol Phys 9: 311–319PubMedGoogle Scholar
  75. Harwood AR, Lawson VG (1982) Radiation therapy for melanomas of the head and neck. Head Neck Surg 4: 468–474PubMedGoogle Scholar
  76. Head and Neck Contracts Program (1987) Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report of the Head and Neck Contracts Program. Cancer 60: 301–311Google Scholar
  77. Hoederat A, Sark H, Stuschke M et al. (1996) Radiation therapy of primary extranodal non-Hodgkin’s lymphoma of head and neck. Results of a prospective multicenter study. Strahlenther Onkol 172: 356–366Google Scholar
  78. Hölzel D, Klamert A, Schmidt M (1996) Krebs.Häufigkeiten,Befunde und Behandlungsergebnisse. Zuckschwerdt, MünchenGoogle Scholar
  79. Hong WK, Itri LM (1994) Retinoids and human cancer.In:Sporn MB, Roberts AB, Goodman DS (eds) The retinoids. Biology, chemistry, and medicine, 2nd edition. Raven Press, Philadelphia, pp 597–630Google Scholar
  80. Horiot IC, Le Fur R,N’GuyenTetal. (1992) Hyperfractionated versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25: 231–241PubMedGoogle Scholar
  81. Hornstein OP (1996) Erkrankungen des Mundes. Kohlhammer, Stuttgart, S 459–532Google Scholar
  82. International Union Against Cancer (1997)TNM Klassifikation malignerTumoren, 5. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  83. Iro H, Hosemann W (1993) Minimally invasive surgery in otorhinolaryngology. Eur Arch Otorhinolaryngol 250: 1–10PubMedGoogle Scholar
  84. Iro H,Waldfahrer F (1996) Präoperatives Staging und chirurgischeTherapie von Kopf-Hals-Tumoren.Onkologe 2: 339–345Google Scholar
  85. Iro H, Waldfahrer F, Gewalt K, Zenk J, Altendorf-Hofmann A (1995) Enoral/transoral surgery of malignancies of the oral cavity and the oropharynx. Adv Otorhinolaryngol 49: 191–195PubMedGoogle Scholar
  86. Iro H,Waldfahrer F, Altendorf-Hofmann A,Weidenbecher M, Sauer R, Steiner W (1998) transoral laser surgery of supraglottic cancer:a follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 124: 1245–1250Google Scholar
  87. Jarez P, Fernandez PL, Campo E et al. (1994) PRAD-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54: 48134817Google Scholar
  88. Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J, Vaskovic Z, Tadic L (2000) Hyperfractionated radiotherapy with or without concurrent low dose daily cis-platin in locally advanced squamous cell carcinoma of the head and neck:a prospective randomized trial.) Clin Oncol 18: 1458–1464Google Scholar
  89. Jones AS (2000)Tumour suppressor genes and head and neck cancer. Adv Otorhinolaryngol 56: 249–260Google Scholar
  90. Kadish S, Goodman M, Wine CC (1976) Olfactory neuroblastoma: A clinical analysis of 17 cases.Cancer 37: 1571–1576Google Scholar
  91. Kagei K, Shirato H, Nishioka T et al. (2000) Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomo-graphic simulation. Radiother Oncol 54: 117–121PubMedGoogle Scholar
  92. Kingdom TT, Kaplan MJ (1995) Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck 17: 184–189PubMedGoogle Scholar
  93. Kirschner MJ,Fietkau R,Waldfahrer H,Iro H, Sauer R (1997) ZurTherapie von zervikalen Lymphknotenmetastasen ohne bekannten Primärtumor. Strahlenther Onkol 173: 362–368Google Scholar
  94. Kish,JA, EnsleyJF,Jacobs J,Weaver A, Cummings G,AI-Sarraf M (1985) Randomised trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56: 2740–2744Google Scholar
  95. Kleinsasser O (1987) Tumoren des Larynx und des Hypopharynx.Thieme, Stuttgart Kraus DH, Levine HL ( 1997 ) Nasal neoplasia.Thieme, StuttgartGoogle Scholar
  96. Kropveld A, Slootweg PJ, Blankenstein MA,Terhaard CH, Hordijk GJ (1998) Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope 108: 1548–1552Google Scholar
  97. Krull A, Schwarz R, Engenhardt R et al. (1996) European results in neutron therapy of malignant salivary gland tumours.Bull Cancer Radiother 83 Suppl 125s-129 sGoogle Scholar
  98. Krull A, Schwarz R, Heyer D,Timm H, Schmidt R (1995) Results of neutron therapy in recurrent malignant salivary gland tumors in the head and neck area. Strahlenther Onkol 171: 265–271Google Scholar
  99. Kwong D, Sham J, Choy D (1994) The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int J Radiat Oncol Biol Phys 30: 1029–1036PubMedGoogle Scholar
  100. Laramore GE, Scott CB, AI-Sarraf M et al. (1992) Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck:Report on intergroup study 0034. Int J Radiat Oncol Biol Phys 23: 705–713PubMedGoogle Scholar
  101. Lazar AD, Winter MR, Nogueira CP et aI. (1998). Loss of heterozygosity at 11 q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease. Clin Cancer Res 4: 2787–2793Google Scholar
  102. Lee AW, Poon YF, Foo W et al. (1992) Retrospective analysis of 5037 patients with naospharyngeal carcinoma treated during 1976–1985: Overall survival and pattern of failure. Intl Radiat Oncol Biol Phys 23: 261–270Google Scholar
  103. Leemans CR,Tiwari R, Nauta JJP, von der Waal I, Snow GB (1993) Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma.Cancer 71: 452–456Google Scholar
  104. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88: 890–899Google Scholar
  105. Leibel SA, Scott CB, Muhiuddin M, Marcial VA, Coia LR, Davis LW, Fuks Z (1991) The effect of loco-regional control on distant metastatic dis-semination in carcinoma of the head and neck: Results of an analysis from the RTOG database. Int J Radiat Oncol Biol Phys 21: 549–556Google Scholar
  106. Leitlinien der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- and Halschirurgie (2000) Onkologie des Kopf-Hals-Bereiches. H NO 48:104–118Google Scholar
  107. Lindberg R (1972) Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29: 1446–1449PubMedGoogle Scholar
  108. Lippert BM, Werner JA (2001) Metastases in Head and Neck Cancer. Proceedings of the 2nd international Symposium.Tectum, MarburgGoogle Scholar
  109. Lucente FE, Lawson W, Novick NL (1995) The external ear. Saunders, PhiladelphiaGoogle Scholar
  110. Maier H, Weidauer H (1991) Krebsrisiken im Kopf-Hals-Bereich. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  111. Martin H,Sugerbaker EL (1941) Cancer of the tonsil. Am J Surg 52: 158–196Google Scholar
  112. McDonald S, Meyerowitz C, Smudzin T, Rubin P (1994) Preliminary results of a pilot study using WR 2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int J Radiat On-col Biol Phys 29: 747–754Google Scholar
  113. Mendenhall WM, Parsons JT, Buatti JM, Stringer SP, Million RR, Cassisi NJ (1995) Advances in radiotherapy for head and neck cancer. Semin Surg Oncol 11: 256–264PubMedGoogle Scholar
  114. Meoz-Mendez RT, Fletcher GH, Guillamondeque OM (1978) Analysis of the results of irradiation in the treatment of squamous cell carcinoma of the pharyngeal walls. Int J Radiat Oncol Biol Phys 4: 579–585PubMedGoogle Scholar
  115. Merino OR, Lindberg RD, Fletcher GH (1977) An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40: 145–151PubMedGoogle Scholar
  116. Merlano M, Benasso M, Corvo R et al. (1996) Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.) Natl Cancer Inst 88: 583–589Google Scholar
  117. Merlano M,Vitale V, Rosso R et al. (1992) Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327: 1115–1121Google Scholar
  118. Mika H (1987) Vergleich von intraarterieller and systemischer Chemotherapie bei Kopf- and Halstumoren. In:Sauer R, Schwab W (Hrsg) Kombinationstherapie der Oropharynx- and Hypopharynxkarzinome. Urban and Schwarzenberg, München, 5 155–157Google Scholar
  119. Million RR,Cassisi NJ (1994) Management of head and neck cancer,2nd edition.J.B. Lippincott, PhiladelphiaGoogle Scholar
  120. Moore C (1971) Cigarette smoking and cancer of the mouth, pharynx and Iarynx.JAMA 218: 553–558Google Scholar
  121. Munro Ai (1995) An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71: 83–91Google Scholar
  122. Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, Kerekhanjanarong V,Sriuranpong V,Yenrudi S,Supiyaphun P,Voravud N (1997) Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 76: 770–776PubMedGoogle Scholar
  123. Myers EN, Suen JY (1996) Cancer of the head and neck, 3rd edition. Saunders PhiladelphiaGoogle Scholar
  124. Niewald M, Barbie O, Schnabel K, Engel M, Schedler M, Nieder C, Berberich W (1996) Risk factors and dose-effect relationship for osteoradionecrosis after hyperfractionated and conventionally fractionated radiotherapy for oral cancer. Br J Radio! 69: 847–851Google Scholar
  125. O’Sullivan, Warde P, Grice B et al. (1996) Assessment of contralateral neck failure in 229 cases of carcinoma of the tonsillar region treated with techniques desinged to spare contralateral parotid function. Int J Radiat Oncol Biol Phys 36 [Suppl]: 165Google Scholar
  126. Olsen KD, Caruso M, Foote RL et al. (1994) Primary head and neck cancer: Hisotpathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg 120: 1370–1374Google Scholar
  127. Overgaard J (1994) Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.Oncol Res 6: 509–518Google Scholar
  128. Overgaard J, Gonzalez-Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Melia O, Bentzen SM (1996) Hyperthermia as adjuvant to radiation therapy for recurrent or metastatic malignant melanoma. A multicenter randomised trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 12: 3–20Google Scholar
  129. Overgaard J, Overgaard M, Hansen PV, von der Maase H (1986) Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol 5: 183–192PubMedGoogle Scholar
  130. Pernot M, Mal issa rd L, Hoffstetter S et al. (1994) The study of tumoral, radio-biological, and general health factors that influence resutls and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 29: 673–679PubMedGoogle Scholar
  131. Peters L J, Harrison ML, Dimery IW, Fields R, Goepfert H, Oswald KU (1988) Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx.Inti Radiat Oncol Biol Phys 14: 623–633Google Scholar
  132. Peters LJ, Goepfert H, Ang KK et al. (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prespective randomized trial. Int J Radiat Oncol Biol Phys 26: 3–11PubMedGoogle Scholar
  133. Pignon JP, Bourhis J, Domenge C, Designé, on behalf of the MACH-HN Collaborative Group (2000) Chemotherapy added to locoregional treatment for head and neck squamous cell carcinomas:three metaanalyses of updated individual data. Lancet 355: 949–955Google Scholar
  134. Pindborg JJ (1982) Krebs und Vorkrebs der Mundhöhle. Quintessenz, BerlinGoogle Scholar
  135. Pless M (2000) Bedeutung der Chemotherapie in der kurativen Therapie von Kopf-Hals-Tumoren. HNO 48: 873–878PubMedGoogle Scholar
  136. Poppendieck J (1987) Zur Häufigkeit von Mehrfachtumoren im oberen Aerodigestivtrakt. Routinemäßige Panendoskopie? HNO 35: 19–23PubMedGoogle Scholar
  137. Ravasz LA,Terhaard CHJ, Hordijk GJ (1990) Radiotherapy in epithelial tumors of the parotid gland:case presentation and literature review. Int J Radiat Oncol Biol Phys 19: 55–59Google Scholar
  138. Renan MJ (1993) How many mutations are required fortumorigenesis? Implications from human cancer data. Mol Carcinog 7: 139–146PubMedGoogle Scholar
  139. Robbins KT (2000) The evolving role of combined modality therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 126: 265269Google Scholar
  140. Rudert H (1991) Larynx- und Hypopharynxkarzinome–Endoskopische Chirurgie mit dem Laser.Möglichkeiten und Grenzen. Eur Arch Otorhinolaryngol 1 [Suppl]: 3–18Google Scholar
  141. Sanchíz F, Milli A,Torner J, Bonet F, Artola N, Carreno L, Moya LM, Riera D, Ripol S,Cirera L (1990) Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 19: 1347–1350Google Scholar
  142. Sanguinati G,Geara FB, Garden AS,Tucker SL, Ang KK, Morrison WH, Peters U (1997) Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 37: 985–996Google Scholar
  143. Schantz SP (1993) Carcinogenesis, markers, staging, and prognosis of head and neck cancer. Curr Op Oncol 5: 483–490Google Scholar
  144. Schuller DE, Metch B, Stein DW, Mattox D, McCracken JD (1988) Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98: 1205–1211Google Scholar
  145. Schwab W, Clasen B, Steinhoff Hi (1987) Neue und geänderte Richtlinien zum TNM-System im Kopf-Hals-Bereich. HNO 35: 112–118PubMedGoogle Scholar
  146. Scully C, Field JK,Tanzawa H 2000 ) Genetic abberations in oral or head and neck squamous cell carcinoma (3 parts). Oral Oncol 36: 256–263, 311–327, 404–413Google Scholar
  147. SECOG, Cancer Research Campaign Clinical Trial Centre (1986) A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Europ J Surg Oncol 12: 289–295Google Scholar
  148. Seifert G (1996) Oralpathologie I. Pathologie der Speichedrüsen. Springer, Berlin Heidelberg New York TokyoSeifert G, Miehlke A, Haubrich J, Chilla R ( 1984 ) Speicheldrüsenkrankheiten.Thieme, StuttgartGoogle Scholar
  149. Shanmugaratnam K (1991) Histological typing of tumours of the upper respiratory tract and ear, 2nd edition. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  150. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK, Hittelman WN (1994) Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54: 321–326PubMedGoogle Scholar
  151. Shockley WW, Pillsbury HC (1993) The neck. Diagnosis and surgery. Mosby, St. LouisGoogle Scholar
  152. Sidransky D (2001) Cancer of the head and neck. molecular biology of head and neck tumors. In: de Vita VT, Hellman S, Rosenberg SA (eds) Cancer–principles and practice of oncology, 6th edition. Lippincott-Raven, Philadelphia, pp 789–796Google Scholar
  153. Silver CE, Ferlito A (1996) Surgery for cancer of the larynx and related structures, 2nd edition. Saunders, PhiladelphiaGoogle Scholar
  154. Spiro RH (1986) Salivary neoplasms.Overview ofa 35-year experience with 2807 patients. Head Neck Surg: 8: 177–184PubMedGoogle Scholar
  155. Staar S, Rudat V, Stuetzer H et al. (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50: 1161–1171PubMedGoogle Scholar
  156. Steiner W (1988) Experience in endoscopic laser surgery of malignant tumours of the upper aerodigestive tract. Adv Otorhinolaryngol 3: 9 135–144Google Scholar
  157. Steiner W (1993) Krebsfrüherkennung im Bereich der oberen Luft- und Speisewege. HNO 41:360–367, 497–503Google Scholar
  158. Steiner W (1994) Therapie des Hypopharynxkarzinoms. HNO 42: 4–13, 84–88,104–112,147–156, 157–165Google Scholar
  159. Steiner W (1997) Endoskopische Laserchirurgie der oberen Luft- und Speisewege.Thieme, StuttgartGoogle Scholar
  160. Steiner W, Reck R, Dühmke E (1990) Funktionserhaltende Therapie des frühen Larynxkarzinoms.Thieme, StuttgartGoogle Scholar
  161. Steinhart H,ConstantinidisJ,Iro H (1998) Kehlkopferhaltende Chirurgie bei Karzinomen der Rachenhinterwand durch Rekonstruktion mit freien Lappen. HNO 46: 135–139Google Scholar
  162. Stranc MF, Fogel M,Dische S (1987) Comparison of lip function:surgeryversus radiotherapy. Br J Plastic Surg 40: 598–604Google Scholar
  163. Strauch B, Vasconez LO, Hall-Findley EJ (1998) Grabb’s encyclopedia of flaps,volume 1:head and neck, 2nd edition. Lippincott Raven, PhiladelphiaGoogle Scholar
  164. Suarez 0 (1963) El problema de las metastasis linfaticas y alejadas del cancer de laringe e hipofaringe. Rev Otorrinolaringol 23: 83–99Google Scholar
  165. Subramaniam R, Chilla R (1995) Halslymphknotenmetastasen bei unbekanntem Primärtumor.HNO43:299–303Google Scholar
  166. Taylor IV SG, Murthy AK, Vannetzel JM et al. (1994) Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12: 385–395PubMedGoogle Scholar
  167. Trog D, Bank P, WendtTG, Koscielny S, Beleites E (1999) Daily Amifostine given concomitantly to chemoradiation in head and neck cancer:A pilot study. Strahlenther Oncol 175: 444–449Google Scholar
  168. Turner SL,Slevin NJ, Gupta NK, Swindell R (1996) Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity–evaluation of late morbidity and a watch policy for the clinically negative neck. Radiother Oncol 41: 21–29Google Scholar
  169. Tuyns AJ, Estève J, Raymond L et al. (1988) Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC International Case-Control Study in Turin and Varese (Italy), Zaragoza and Navarra ( Spain ), Geneva (Switzerland) and Calvados (France). Int J Cancer 41: 483–491Google Scholar
  170. UICC- International Union Against Cancer, Wittekind C, Meyer HJ, Bootz F (2002) TNM-Klassifikation maligner Tumoren, 6. Auflage. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  171. Urken ML, Cheney ML, Sullivan MJ, Billder HF (1995) Atlas of regional and free flaps for head and neck reconstruction. Raven Press, PhiladelphiaGoogle Scholar
  172. Van den Bogaert W, van der Schueren E, Horiot JC et al. (1995) The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer:long-term results and side effects. Radiother Oncol 35: 91–99PubMedGoogle Scholar
  173. Van der Planken, HJM,Tiwari RM, Karim ABM (1997) Treatment of cervical lymph node metastasis form an unknown primary tumor, with a review of the literature. Strahlenther Onkol 173: 163–169Google Scholar
  174. Van Dieren EB,Nowak PJCM,Wijers OB,van Sörnsen de Koste JR,van der Est H, Binnekamp DP, Heijmen BJM, Levendag PD (2000) Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary caners of the oropharynx and larynx, including the elective neck. Int J Radiat Oncol Biol Phys 47: 1299–1309PubMedGoogle Scholar
  175. Vanderbrouck C, Sancho H, Le Fur R, Richard JM, Cachin Y (1977) Results of a randomized clinical trial of preoperative irradiation versus postoperative in treatment of tumors of the hypopharynx. Cancer 39: 1445–1449Google Scholar
  176. Venook AP, Tseng A Jr, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD (1987) Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the NorthernCalifornia Oncology Group.J Clin Oncol 5: 951–955Google Scholar
  177. Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients wich advanced laryageal cancer. N Engl J Med 324: 1685–1690Google Scholar
  178. Vidyasagar MS, Fernandes DJ, Kasturi DP,Akhileshwaran R,Rao K, Rao S, Rao RV, Solomon JG (1992) Radiotherapy and verrucous carcinoma of the oral cavity. A study of 107 cases. Acta Oncol 31: 43–47Google Scholar
  179. Vokes EE,Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328: 184–194Google Scholar
  180. VUMCA I trial (1996) International Nasopharynx Cancer Study Group Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cis-platin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (=N2, MO) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.lnt J Radiat Oncol Biol Phys 35: 463–469Google Scholar
  181. Wagner G, Hermanek P (1995) Organspezifische Tumordokumentation. Springer, BerlinGoogle Scholar
  182. Waldfahrer F, Heinritz H, Kraus T, Iro H (1995) Plasmozytome im HNO-Bereich. HNO 43: 111–129PubMedGoogle Scholar
  183. Waldfahrer F, Iro H (2001) Tumormarker und andere Laborparameter In: Böttcher HD, Wendt TG, Henke M (Hrsg) Klinik des Rezidivtumors im Kopf-Hals-Bereich. Zuckschwerdt, MünchenGoogle Scholar
  184. Wang CC (1991) Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 14: 5–8PubMedGoogle Scholar
  185. Wang CC (1997) Radiation therapy for head and neck neoplasms, 3rd edition. Wiley-Liss, New YorkGoogle Scholar
  186. Weber PC,Johnson JT, Myers EN (1994) The impact of bilateral neck dissection on pattern of recurrence and survival in supraglottic carcinoma. Arch Otolaryngol Head Surg 120: 703–706Google Scholar
  187. Wendt TG, Grabenbauer GG, Rödel C et al. (1998) Simultaneous radio-chemotherapy versus radiotherapy alone in advanced head and neck cancer:a randomized multicenter study.J Clin Oncol 16: 1318–1324Google Scholar
  188. WernerJA (1997) Aktueller Stand der Versorgung des Lymphabflusses maligner Kopf-Hals-Tumoren. Verhandlungsbericht 1997, Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Springer, Berlin Heidelberg New Yorl Tokyo, S 47–86Google Scholar
  189. Wildfang I et al. (1999) Low-dose gemcitabine with radiotherapy in advanced head and neck and thyroid tumors: a phase II study. Proc Am Soc Clin Oncol 17:AbstractGoogle Scholar
  190. Withers HR, Peters U,Taylor JMG et al. (1995) Local control of the tonsil by radiation therapy: An analysis of pattern of fractionation in nine Insitutions. Int J Radiat Oncol Biol 33: 549–562Google Scholar
  191. Zelefsky MJ, Harrison LB, Fass DE, Armstrong JG, Shah JP, Strong EW(1992) Postoperative radiation therapy for squamous cell carcinoma of the oral cavity and oropharynx:impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 25: 17–21Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • T. G. Wendt
  • H. Iro
  • F. Waldfahrer

There are no affiliations available

Personalised recommendations